This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Protalix Ltd.. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Givataim, IL (2015)
- Petach-Tikva, IL (2017 - 2020)
Company Filing History:
Years Active: 2015-2025
Title: Talia Shekhter: Innovator in Protein Structures
Introduction
Talia Shekhter is a prominent inventor based in Petach-Tikva, Israel. She has made significant contributions to the field of biochemistry, particularly in the development of innovative protein structures. With a total of 5 patents to her name, her work has the potential to impact medical treatments significantly.
Latest Patents
Among her latest patents is the invention of stabilized alpha-galactosidase and its uses. This patent describes multimeric protein structures that consist of at least two alpha-galactosidase monomers covalently linked via a linking moiety. The patent outlines a process for preparing these structures and methods for treating Fabry disease through the administration of the multimeric protein. The disclosed structures demonstrate improved performance, showcasing enhanced activity and longer-lasting effects under both lysosomal conditions and in serum environments.
Career Highlights
Talia Shekhter is currently associated with Protalix Ltd., where she continues to advance her research and development efforts. Her innovative work in protein structures has positioned her as a key player in the biopharmaceutical industry.
Collaborations
Shekhter collaborates with notable colleagues, including Avidor Shulman and Ilya Ruderfer, who contribute to her research endeavors and help drive her projects forward.
Conclusion
Talia Shekhter's contributions to the field of biochemistry, particularly through her patented innovations, highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
